The 5-year progression-free survival for grade 1 is 95.7%, for grade 2 is 81.8%, and for grade 3 is 46.7%, while the 10-year progression-free survival for grade 1 is 90.4.7%, and for grade 2 is 69.4%.

The tumor grade in meningioma is considered a significant prognostic factor in patients undergoing radiation treatment after surgery.

The recurrence rate of meningioma is associated with the extent of surgical removal. Using the original Simpson grading system, the overall recurrence rates for grades 1, 2, 3, and 4 are 9%, 19%, 29%, and 40%, respectively.